Financials

  • Market Capitalization 447.63 M
  • Employee 116
  • Founded 2013
  • CEO Shankar Musunuri
  • Website www.ocugen.com
  • Headquarter Delaware, United States
  • FIGI BBG00194VJB1
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-5.88
市销率
106.63

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
2969
DNA
Ginkgo Bioworks Holdings, Inc. Class A Common Stock
6.91 USD-0.43%-5.60%-14.80%-22.18%444.59 M USD
2972
EVMN
Evommune, Inc. Common Stock
12.51 USD+0.16%-11.15%+12.30%-27.77%454.01 M USD
2978
AVIR
Atea Pharmaceuticals, Inc. - common stock
5.67 USD+3.28%+3.47%+19.87%+76.64%454.76 M USD
2998
PRLD
Prelude Therapeutics Incorporated - Common Stock
5.49 USD0.00%-16.06%+18.06%+390.18%438.12 M USD

新闻